News Focus
News Focus
Followers 88
Posts 3088
Boards Moderated 0
Alias Born 09/07/2014

Re: beartrap12 post# 823378

Tuesday, 04/28/2026 4:11:57 PM

Tuesday, April 28, 2026 4:11:57 PM

Post# of 825901
I know GZ wrote this in his email to 10Baggerz:

Whether it’s a full or conditional approval remains to be determined, but either way it will enable us to launch DCVax-L in the U.K.



...But I believe he's hedging his bet, covering his a.., or trying to appear like NWBO management is not overly confident or advertising approval before we have approval.

I also think George is not thinking like an investor, but like a scientist, which he should. He's not thinking about what "conditional approval" sounds like to would-be investors.

I don't think DCVax-L needs a conditional approval for n and rGBM because they've already, technically, been through the requirements of conditional approval which, as I understand it, is having the treatment tested in real life on real patients for a certain amount of time. Think compassionate care, which the company has been offering for 4 years. And think of the NHS case-by-case program where the UK already pays for its citizens to get DCVax-L.

No, I think conditional approval for r/n GBM is very unlikely.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News